Gene therapy of chondrosarcoma using retrovirus vectors encoding the herpes simplex virus thymidine kinase gene

International Journal of Oncology

Volumn 14, Issue 6, 1999, Pages 1137-1141

  Seto, Masashi ^a   Wakabayashi, Hiroki ^a   Yamazaki, Takashi ^a   Sonoda, Jun ^a   Shinto, Yoshitaka ^b   Uchida, Atsumasa ^a  

^a MIE UNIVERSITY   (Japan)

^b Department of Radiology   (Japan)

Author keywords

Bystander effect; Chondrosarcoma; Gene therapy; Retrovirus vectors; Suicide gene

Indexed keywords

ANTIVIRUS AGENT; BETA GALACTOSIDASE; GANCICLOVIR; THYMIDINE KINASE;

ANIMAL; ARTICLE; AVIAN SARCOMA VIRUS; BONE TUMOR; CANCER TRANSPLANTATION; CELL CULTURE; CELL DIVISION; CHONDROSARCOMA; COCULTURE; DOSE RESPONSE; DRUG EFFECT; ENZYMOLOGY; ESCHERICHIA COLI; GENE THERAPY; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; HERPES SIMPLEX VIRUS; HUMAN; INSTITUTE FOR CANCER RESEARCH MOUSE; MALE; METHODOLOGY; MOLONEY LEUKEMIA ONCOVIRUS; MOUSE; NUDE MOUSE; PATHOLOGY;

ANIMALS; ANTIVIRAL AGENTS; AVIAN SARCOMA VIRUSES; BETA-GALACTOSIDASE; BONE NEOPLASMS; CELL DIVISION; CHONDROSARCOMA; COCULTURE TECHNIQUES; DOSE-RESPONSE RELATIONSHIP, DRUG; ESCHERICHIA COLI; GANCICLOVIR; GENE THERAPY; GENETIC VECTORS; HUMANS; MALE; MICE; MICE, INBRED ICR; MICE, NUDE; MOLONEY MURINE LEUKEMIA VIRUS; NEOPLASM TRANSPLANTATION; SIMPLEXVIRUS; THYMIDINE KINASE; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0033141889     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.14.6.1137     Document Type: Article

References (18)

1. Culver KW, Ram Z, Walbridge S, Ishii H, Oldfield EH and Blaese RM: In vivo gene transfer with retroviral vector-producer cell for treatment of experimental brain tumors. Science 256: 1550-1552, 1992.
2. Culver KW: Gene therapy for malignant neoplasms of the CNS. Bone Marrow Transplant 18 (Suppl 3): S6-S9, 1996.
3. Gansbacher B, Bannerji R, Danniels B, Zier K, Cronin K and Gilboa E: Retroviral vector-mediated γ-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity. Cancer Res 50: 7820-7825, 1990.
4. Caruso M, Panis Y, Gagandeep S, Houssin D, Salzmann JL and Klatzmann D: Regression of established macroscopic liver metastases after in situ transduction of a suicide gene. Proc Natl Acad Sci USA 90: 7024-7028, 1993.
5. Ezzeddine ZT, Martuza RI, Platika D, Short MP, Malick A, Choi B and Breakfield XO: Selective killing of glioma cells in culture and in vivo by retrovirus transfer of the herpes simplex virus thymidine kinase. New Biol 3: 608-614, 1991.
6. Ram Z, Culver KW, Walbridge R, Blaese RM and Oldfield EH: In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res 53: 83-88, 1993.
7. Pitts JD: Cancer gene therapy: a bystander effect using the gap junction pathway. Mol Carcinog 11: 127-130, 1994.
8. Abe A, Takeo T, Emi N, Tanimoto M, Ueda R, Yee JK, Freedmann T and Saito H: Transduction of a drug-sensitivity toxic gene into human leukemia cell lines with a novel retroviral vector (43611). Proc Soc Exp Biol Med 203: 354-359, 1993.
9. Hasegawa Y, Emi N, Shimokata K, Abe A, Kawabe T, Hasegawa T, Kirioka T and Saito H: Gene transfer of herpes simplex virus type I thymidine kinase gene as a drug sensitivity gene into human lung cancer cell lines using retrovirus vectors. Am J Respir Cell Mol Biol 8: 655-661, 1993.
10. Lixu YJ-K, Wolff JA and Friedman T: Factors affecting long term stability of Moloncy leukemia virus-based vectors. Virology 171: 331-341, 1989.
11. Miller AD and Buttimore C: Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol Cell Biol 6: 2895-2902, 1986.
12. Quade K: Transformation of mammalian cells by avian mylocytomatosis virus and avian erythroblastosis virus. Virology 98: 461-465, 1979.
13. Miyanohara A, Sharkey MF, Witztum JL, Steinberg D and Freidmann T: Efficient expression of retroviral-vecor-transduced human low density lipoprotein (LDL) receptor in LDL receptor-deficient rabbit fibroblasts in vitro. Proc Natl Acad Sci USA 85: 6538-6542, 1988.
14. Carmichael J, De Graff WG, Gazdar AF, Minna JD and Mitchell JB: Evaluation of a tetrazolium-based semiautomated colorimetric assessment of chemosensitivity testing. Cancer Res 47: 936-942, 1987.
15. Klatzmann D: Gene therapy for metastatic malignant melanoma: evaluation of tolerance to intratumoral injection of cells producing recombinant retroviruses carrying the herpes simplex virus type 1 thymidine kinase gene, to be followed by ganciclovir administration. Hum Gene Ther 7: 255-267, 1996.
16. The DNA Recombinant Advisory Committee of the NIH: Clinical protocols. Cancer Gene Ther 2: 67-74, 1995.
17. Bennet MVL, Barrio LC, Bargiello TA, Spray DC, Hertzberg E and Saez JC: Gap junction: new tools, new answers, new questions. Neuron 6: 305-320, 1991.
18. Kolberg R: The bystander effect in gene therapy: great, but does it work? J Natl Inst Health Res 6: 62-64, 1994.